Infertility Drugs Market 2022-2027

1
Global Infertility Drugs Market Research and
Forecast Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Infertility Drugs Market Research
Report According to the latest report by IMARC
Group, titled Infertility Drugs Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027 the global infertility
drugs market reached a strong growth in
2021.  Infertility drugs consist of numerous
medications that are used to treat infertility
and improve the reproductive health of an
individual. Some of the commonly used infertility
drugs include aromatase inhibitors,
gonadotrophins, biguanides, ovulatory stimulants,
selective estrogen receptor modulators (SERMs),
dopamine agonists, tricyclic antidepressants,
etc. These drugs function by stimulating
ovulation and follicle development of the ovary
in women, as well as help to restore testosterone
levels and improve the quality of sperm in
men. Request Free Sample Report
https//www.imarcgroup.com/infertility-drugs-marke
t/requestsample
4
Report Description and Highlights
Report Description

Global Infertility Drugs Market Trends The
growing incidences of infertility and
miscarriages, particularly among the modern
couples, are primarily driving the adoption of
infertility drugs. In line with this, the rising
consumer awareness towards several benefits of
infertility drugs in enhancing the chances of
pregnancy in couples is also augmenting the
market growth on a global level. Furthermore,
numerous initiatives are being undertaken by the
NGOs and leading product manufacturers for
improving the visibility of the available
treatment options, thereby catalyzing the demand
for infertility drugs. Additionally, various key
players are investing in RD activities to launch
innovative infertility drugs with enhanced
efficacy, fewer side effects, lower dosage
requirements, etc. Several other factors,
including the escalating demand for generic
medicines, rising consumer expenditure
capacities, improving healthcare infrastructure,
etc., are expected to drive the global
infertility drugs market in the coming
years. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2022-2027).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Drug Class
Gonadotropin Aromatase Inhibitors
Selective Estrogen Receptor Modulators
(SERMs) Biguanides Others Bre
akup by Route of Administration
Oral Intravenous Sub
cutaneous Intramuscular Breakup by Dist
ribution Channel Hospital Pharmacies
Retail Pharmacies Others

6
Report Description and Highlights
Report Description
Breakup by End User Male Fema
le Breakup by Region North America
United States Can
ada Asia Pacific China
Japan India
South Korea Aus
tralia Indonesia
Others Europe Germa
ny France Unit
ed Kingdom

7
Report Description and Highlights
Report Description
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa Note We are updati
ng our reports, If you want latest primary and
secondary data (2022-2027) with Cost Module,
Business Strategy, Distribution Channel, etc.
Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Bayer AG Ferring Pharmaceuticals Livzon Pharmaceut
  ical Group Inc. Mankind Pharma Merck Co. Inc. Me
  rck KGaA Novartis AG Pfizer Inc. Sanofi S.A. Thera
  mex.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/infertility-drugs-marke
  t

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us